Glycemic variability on continuous glucose monitoring system predicts rapid progression of non-culprit lesions in patients with acute coronary syndrome

Circulation Journal

Volumn 79, Issue 10, 2015, Pages 2246-2254

  Kataoka, Shunsuke ^a   Gohbara, Masaomi ^a   Iwahashi, Noriaki ^a   Sakamaki, Kentaro ^b   Nakachi, Tatsuya ^a   Akiyama, Eiichi ^a   Maejima, Nobuhiko ^a   Tsukahara, Kengo ^a   Hibi, Kiyoshi ^a   Kosuge, Masami ^a   Ebina, Toshiaki ^a   Umemura, Satoshi ^c   Kimura, Kazuo ^a  

^a Division of Cardiology Department of Internal Medicine   (Japan)

^b Department of Biostatistics and Epidemiology ^*  (Japan)

^c YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Acute coronary syndrome; Glycemic variability; Rapid progression

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; ISOSORBIDE DINITRATE; GLUCOSE BLOOD LEVEL;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD GLUCOSE MONITORING; CORONARY ARTERY DISEASE; CORONARY IMAGING CATHETER; DISEASE COURSE; FEMALE; GLUCOSE REGULATION SYSTEM; GLYCEMIC INDEX; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEAN AMPLITUDE OF GLYCEMIC EXCURSION; MEDICAL PARAMETERS; OBSERVATIONAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RAPID PROGRESSION; STABLE ANGINA PECTORIS; STENOSIS; BLOOD; CLINICAL TRIAL; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGIC MONITORING;

ACUTE CORONARY SYNDROME; AGED; BLOOD GLUCOSE; FEMALE; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PROSPECTIVE STUDIES;

EID: 84942520712     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-15-0496     Document Type: Article

References (31)

1. Waters D, Craven TE, Lesperance J. Prognostic significance of progression of coronary atherosclerosis. Circulation 1993; 87: 1067-1075.
2. Kaski JC, Chester MR, Chen L, Katritsis D. Rapid angiographic progression of coronary artery disease in patients with angina pectoris: The role of complex stenosis morphology. Circulation 1995; 92: 2058-2065.
3. Rioufol G, Finet G, Ginon I, Andre-Fouet X, Rossi R, Vialle E, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: A three-vessel intravascular ultrasound study. Circulation 2002; 106: 804-808.
4. Asakura M, Ueda Y, Yamaguchi O, Adachi T, Hirayama A, Hori M, et al. Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: An angioscopic study. J Am Coll Cardiol 2001; 37: 1284-1288.
5. Burke AP, Kolodgie FD, Farb A, Weber DK, Malcom GT, Smialek J, et al. Healed plaque ruptures and sudden coronary death: Evidence that subclinical rupture has a role in plaque progression. Circulation 2001; 103: 934-940.
6. Zouridakis E, Avanzas P, Arroyo-Espliguero R, Fredericks S, Kaski JC. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation 2004; 110: 1747-1753.
7. Zouridakis EG, Schwartzman R, Garcia-Moll X, Cox ID, Fredericks S, Holt DW, et al. Increased plasma endothelin levels in angina patients with rapid coronary artery disease progression. Eur Heart J 2001; 22: 1578-1584.
8. Bando YK, Murohara T. Diabetes-related heart failure. Circ J 2014; 78: 576-583.
9. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006; 295: 1681-1687.
10. D’Archangelo MJ. New guideline supports the development and evaluation of continuous interstitial glucose monitoring devices. J Diabetes Sci Technol 2008; 2: 332-334.
11. Ambrose JA, Winters SL, Arora RR, Haft JI, Goldstein J, Rentrop KP, et al. Coronary angiographic morphology in myocardial infarction: A link between the pathogenesis of unstable angina and myocardial infarction. J Am Coll Cardiol 1985; 6: 1233-1238.
12. Nakachi T, Kosuge M, Hibi K, Ebina T, Hashiba K, Mitsuhashi T, et al. C-reactive protein elevation and rapid angiographic progression of nonculprit lesion in patients with non-ST-segment elevation acute coronary syndrome. Circ J 2008; 72: 1953-1959.
13. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970; 19: 644-655.
14. Diagnosis and classification of diabetes mellitus. Diabetes Care 2013; 36(1): S67-S74.
15. Rioufol G, Zeller M, Dentan G, Laurent Y, L’Huillier I, Ravisy J, et al. Predictors and prognosis for complex coronary lesions in patients with acute myocardial infarction: Data from RICO survey. Am Heart J 2007; 154: 330-335.
16. Goldstein JA, Chandra HR, O’Neill WW. Relation of number of complex coronary lesions to serum C-reactive protein levels and major adverse cardiovascular events at one year. Am J Cardiol 2005; 96: 56-60.
17. Lichtlen PR, Nikutta P, Jost S, Deckers J, Wiese B, Rafflenbeul W. Anatomical progression of coronary artery disease in humans as seen by prospective, repeated, quantitated coronary angiography: Relation to clinical events and risk factors: The INTACT Study Group. Circulation 1992; 86: 828-838.
18. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, et al. Hyperglycemia and acute coronary syndrome: A scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2008; 117: 1610-1619.
19. Yakubovich N, Gerstein HC. Serious cardiovascular outcomes in diabetes: The role of hypoglycemia. Circulation 2011; 123: 342-348.
20. Gohbara M, Iwahashi N, Kataoka S, Hayakawa Y, Sakamaki K, Akiyama E, et al. Glycemic variability determined by continuous glucose monitoring system predicts left ventricular remodeling in patients with a first ST-segment elevation myocardial infarction. Circ J 2015; 79: 1092-1099.
21. JCS Joint Working Group. Guidelines for secondary prevention of myocardial infarction (JCS 2011): Digest version. Circ J 2013; 77: 231-248.
22. Lipska KJ, Venkitachalam L, Gosch K, Kovatchev B, Van den Berghe G, Meyfroidt G, et al. Glucose variability and mortality in patients hospitalized with acute myocardial infarction. Circ Cardiovasc Qual Outcomes 2012; 5: 550-557.
23. Meynaar IA, Eslami S, Abu-Hanna A, van der Voort P, de Lange DW, de Keizer N. Blood glucose amplitude variability as predictor for mortality in surgical and medical intensive care unit patients: A multicenter cohort study. J Crit Care 2012; 27: 119-124.
24. Su G, Mi SH, Tao H, Li Z, Yang HX, Zheng H, et al. Impact of admission glycemic variability, glucose, and glycosylated hemoglobin on major adverse cardiac events after acute myocardial infarction. Diabetes Care 2013; 36: 1026-1032.
25. Teraguchi I, Imanishi T, Ozaki Y, Tanimoto T, Ueyama M, Orii M, et al. Acute-phase glucose fluctuation is negatively correlated with myocardial salvage after acute myocardial infarction. Circ J 2014; 78: 170-179.
26. Teraguchi I, Imanishi T, Ozaki Y, Tanimoto T, Orii M, Shiono Y, et al. Impact of glucose fluctuation and monocyte subsets on coronary plaque rupture. Nutr Metab Cardiovasc Dis 2014; 24: 309-314.
27. Buscemi S, Re A, Batsis JA, Arnone M, Mattina A, Cerasola G, et al. Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in type 2 diabetes. Diabet Med 2010; 27: 872-878.
28. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: Role of oxidative stress. Circulation 2002; 106: 2067-2072.
29. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
30. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: A marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003; 23: 168-175.
31. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195-2207.